Microsystems technologies for drug delivery to the inner ear

Advanced Drug Delivery Reviews

Volumn 64, Issue 14, 2012, Pages 1650-1660

  Pararas, Erin E Leary ^a   Borkholder, David A ^b   Borenstein, Jeffrey T ^a  

^a CHARLES STARK DRAPER LABORATORY   (United States)

^b Kate Gleason College of Engineering   (United States)

Author keywords

Cochlea; Device; Hearing; Implantable; Intracochlear; Intratympanic; Local drug delivery; Micropump

Indexed keywords

COCHLEA; DEVICE; IMPLANTABLE; INTRACOCHLEAR; INTRATYMPANIC; LOCAL DRUG DELIVERY; MICRO PUMP;

DRUG DELIVERY;

AUDITION;

APOLIPOPROTEIN; BETAMETHASONE; CASPASE INHIBITOR; DEXAMETHASONE; GENTAMICIN; GLUCOCORTICOID; INFLIXIMAB; METHYLPREDNISOLONE; SALICYLATE SODIUM; STEROID; UNCLASSIFIED DRUG; Z VAD FMK;

AUTOIMMUNE DISEASE; CANNULATION; CLINICAL PRACTICE; COCHLEA PROSTHESIS; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; ELECTROCHEMISTRY; ENDOLYMPH; HEARING; HEARING IMPAIRMENT; HUMAN; INNER EAR DISEASE; MENIERE DISEASE; MICROFLUIDICS; NONHUMAN; OSMOTIC PUMP; OTOTOXICITY; PERCEPTION DEAFNESS; PERILYMPH; PRIORITY JOURNAL; PROTEIN CONTENT; REVIEW; SUDDEN DEAFNESS; TINNITUS; TISSUE REGENERATION; VESTIBULAR DISORDER;

ANIMALS; COCHLEAR IMPLANTS; DRUG DELIVERY SYSTEMS; EAR, INNER; HUMANS; LABYRINTH DISEASES; MICROTECHNOLOGY; PHARMACEUTICAL PREPARATIONS;

EID: 84868204442     PISSN: 0169409X     EISSN: 18728294     Source Type: Journal    
DOI: 10.1016/j.addr.2012.02.004     Document Type: Review

References (69)

1. Swan E.E., Mescher M.J., Sewell W.F., Tao S.L., Borenstein J.T. Inner ear drug delivery for auditory applications. Adv. Drug Deliv. Rev. 2008, 60:1583-1599.
2. McCall A.A., Swan E.E., Borenstein J.T., Sewell W.F., Kujawa S.G., McKenna M.J. Drug delivery for treatment of inner ear disease: current state of knowledge. Ear Hear. 2010, 31:156-165.
3. Holley M.C. The auditory system, hearing loss and potential targets for drug development. Drug Discov. Today 2005, 10:1269-1282.
4. Saltzman W.M. Drug Delivery: Engineering Principles for Drug Therapy 2001, Oxford University Press, New York.
5. Chen Z., Kujawa S.G., McKenna M.J., Fiering J.O., Mescher M.J., Borenstein J.T., Swan E.E., Sewell W.F. Inner ear drug delivery via a reciprocating perfusion system in the guinea pig. J. Control. Release 2005, 110:1-19.
6. Fiering J., Mescher M.J., Leary Swan E.E., Holmboe M.E., Murphy B.A., Chen Z., Peppi M., Sewell W.F., McKenna M.J., Kujawa S.G., Borenstein J.T. Local drug delivery with a self-contained, programmable, microfluidic system. Biomed. Microdevices 2009, 11:571-578.
7. Mescher M.J., Swan E.E., Fiering J., Holmboe M.E., Sewell W.F., Kujawa S.G., McKenna M.J., Borenstein J.T. Fabrication methods and performance of low-permeability microfluidic components for a miniaturized wearable drug delivery system. J. Microelectromech. Syst. 2009, 18:501-510.
8. Borkholder D.A. State-of-the-art mechanisms of intracochlear drug delivery. Curr. Opin. Otolaryngol. Head Neck Surg. 2008, 16:472-477.
9. Borkholder D.A., Zhu X., Hyatt B.T., Archilla A.S., Livingston W.J., Frisina R.D. Murine intracochlear drug delivery: reducing concentration gradients within the cochlea. Hear. Res. 2010, 268:2-11.
10. Lynch E.D., Kil J. Compounds for the prevention and treatment of noise-induced hearing loss. Drug Discov. Today 2005, 10:1291-1298.
11. DePalma R.G., Burris D.G., Champion H.R., Hodgson M.J. Blast injuries. N. Engl. J. Med. 2005, 352:1335-1342.
12. Sendowski I., Abaamrane L., Raffin F., Cros A., Clarencon D. Therapeutic efficacy of intra-cochlear administration of methylprednisolone after acoustic trauma caused by gunshot noise in guinea pigs. Hear. Res. 2006, 221:119-127.
13. Rybak L. Mechanisms of cisplatin ototoxicity and progress in otoprotection. Curr. Opin. Otolaryngol. Head Neck Surg. 2007, 15:364-369.
14. Rybak L.P., Whitworth C.A. Ototoxicity: therapeutic opportunities. Drug Discov. Today 2005, 10:1313-1321.
15. Bhandare N., Antonelli P.J., Morris C., Malayapa R.S., Mendenhall W.M. Ototoxicity after radiotherapy for head and neck tumors. Int. J. Radiat. Oncol. Biol. Phys. 2007, 67:469-479.
16. Mosnier I., Bouccara D., Sterkers O. Management of idiopathic sudden sensorineural hearing loss. Oto Rhino Laryngol. Nova 1999, 9:217-223.
17. Ryan A.F., Harris J.P., Keithley E.M. Immune-mediated hearing loss: basic mechanisms and options for therapy. Acta Otolaryngol. 2002, 548:38-43. Suppl.
18. Yang G.S., Song H.T., Keithley E.M., Harris J.P. Intratympanic immunosuppressives for prevention of immune-mediated sensorineural hearing loss. Am. J. Otol. 2000, 21:499-504.
19. Matteson E.L., Fabry D.A., Strome S.E., Driscoll C.L., Beatty C.W., McDonald T.J. Autoimmune inner ear disease: diagnostic and therapeutic approaches in a multidisciplinary setting. J. Am. Acad. Audiol. 2003, 14:225-230.
20. Harner S.G., Driscoll C.L., Facer G.W., Beatty C.W., McDonald T.J. Long-term follow-up of transtympanic gentamicin for Meniere's syndrome. Otol. Neurotol. 2001, 22:210-214.
21. Harner S.G., Kasperbauer J.L., Facer G.W., Beatty C.W. Transtympanic gentamicin for Meniere's syndrome. Laryngoscope 1998, 108:1446-1449.
22. Chia S.H., Gamst A.C., Anderson J.P., Harris J.P. Intratympanic gentamicin therapy for Meniere's disease: a meta-analysis. Otol. Neurotol. 2004, 25:544-552.
23. Hoffer M.E., Allen K., Kopke R., Weisskopf P., Gottshall K.R., Wester D. Transtympanic versus sustained-release administration of gentamicin: kinetics; morphology; and function. Laryngoscope 2001, 111:1343-1357.
24. Hoffer M.E., Wester D., Kopke R.D., Weisskopf P., Gottshall K. Transtympanic management of tinnitus. Otolaryngol. Clin. N. Am. 2003, 36:353-358.
25. Schuknecht H. Pathology of the Ear 1993, Lea and Febiger, Malvern, PA.
26. Tsuji J., Liberman M.C. Intracellular labeling of auditory nerve fibers in guinea pig: central and peripheral projections. J. Comp. Neurol. 1997, 381:188-202.
27. Thalmann R., Comegys T., Thalmann I. Amino acid profiles in inner ear fluids and cerebrospinal fluid. Laryngoscope 1982, 92:321-328.
28. Thalmann I., Kohut R., Ryu J., Thalmann R. High resolution two-dimensional electrophoresis: technique and potential applicability to the study of inner ear disease. Am. J. Otol. 1995, 16:153-157.
29. Thalmann I., Kohut R., Ryu J., Comegys T., Senarita M., Thalmann R. Protein profile of human perilymph: in search of markers for the diagnosis of perilymph fistula and other inner ear disease. Otolaryngol. Head Neck Surg. 1994, 111:273-280.
30. Scheibe F., Haupt H. Biochemical differences between perilymph, cerebrospinal fluid and blood plasma in the guinea pig. Hear. Res. 1985, 17:61-66.
31. Medina J., Drescher D. The amino-acid content of perilymph and cerebrospinal fluid from guinea-pigs and the effect of noise on the amino-acid composition of perilymph. Neuroscience 1981, 6:505-509.
32. Swan E.E., Peppi M., Chen Z., Green K.M., Evans J.E., McKenna M.J., Mescher M.J., Kujawa S.G., Sewell W.F. Proteomics analysis of perilymph and cerebrospinal fluid in mouse. Laryngoscope 2009, 119:953-958.
33. Swan E.E.L., Peppi M., Chen Z., Green K.M., Evans J.E., McKenna M.J., Mescher M.J., Kujawa S.G., Sewell W.F. Proteomics analysis of perilymph and cerebrospinal fluid in mouse. Laryngoscope 2009, 119:953-958.
34. Igarashi M., Ohashi K., Ishii M. Morphometric comparison of endolymphatic and perilymphatic spaces in human temporal bones. Acta Otolaryngol. 1986, 101:161-164.
35. Silverstein H. Use of a new device, the MicroWick, to deliver medication to the inner ear. Ear Nose Throat J. 1999, 78:595-600.
36. Suryanarayanan R., Srinivasan V.R., O'Sullivan G. Transtympanic gentamicin treatment using Silverstein MicroWick in Meniere's disease patients: long term outcome. J. Laryngol. Otol. 2009, 123:45-49.
37. Hill S.L., Digges N.B., Silverstein H. Long-term follow-up after gentamicin application via the Silverstein MicroWick in the treatment of Meniere's disease. Ear Nose Throat J. 2006, 85:494-498.
38. Silverstein H., Jackson L.E., Rosenberg S.I. Silverstein MicroWick for treatment of inner ear disease. Oper. Tech. Otolaryngol. 2001, 12:144-147.
39. Wijck F.v., Staecker H., Lefebvre P.P., et al. Topical steriod therapy using the Silverstein MicroWick in sudden sensorineural hearing loss after failure of conventional treatment. Acta Otolaryngol. 2007, 127:1012-1017.
40. Wijk F.v., Staecker H., Keithley E., Lefebvre P.P. Local perfusion of the tumor necrosis factor alpha blocker infliximad to the inner ear improves autoimmune neurosensory hearing loss. Audiol. Neurootol. 2006, 11:357-365.
41. DeCicco M.J., Hoffer M.E., Kopke R.D., Wester D., Allen K.A., Gottshall K., O'Leary M.J. Round window microcatheter-administered microdose gentamicin: results from treatment of tinnitus associated with Meniere's disease. Int. Tinnitus J. 1998, 4:141-143.
42. Suryanarayanan R. Long-term results of gentamicin inner ear perfusion in Meniere's disease. J. Laryngol. Otol. 2004, 118:489-495.
43. Thomsen J., Charabi S., Tos M. Preliminary results of the new delivery system for gentamicin to the inner ear in patients with Meniere's disease. Eur. Arch. Otorhinolaryngol. 2000, 257:362-365.
44. Weisskopf P., Hoffer M.E., Kopke R.D., Gottshall K., Allen K., Wester D. Microdose gentamicin delivered via the round window microcatheter: a therapeutic option in Meniere's disease. Oper. Tech. Otolaryngol. 2001, 12:154-156.
45. Plontke S.K., Lowenheim H., Preyer S., Leins P., Dietz K., Koitschev A., Zimmermann R., Zenner H.-P. Outcomes research analysis of continuous intratympanic glucocorticoid delivery in patients with acute severe to profound hearing loss: basis for planning randomized controlled trials. Acta Otolaryngol. 2005, 125:830-839.
46. Plontke S.K., Lowenheim H., Mertens J., Engel C., Meisner C., Weidner A., Zimmermann R., Preyer S., Koitschev A., Zenner H.-P. Randomized, double blind, placebo controlled trial on the safety and efficacy of continuous intratympanic dexamethasone delivered via a round window catheter for severe to profound sudden idiopathic sensorineural hearing loss after failure of systemic therapy. Laryngoscope 2009, 119:359-369.
47. Swan E.E.L., Mescher M.J., Sewell W.F., Tao S.L., Borenstein J.T. Inner ear drug delivery for auditory applications. Adv. Drug Deliv. Rev. 2008, 60:1583-1599.
48. Shimogori H., Yamashita H. Efficacy of intracochlear administration of betamethasone on peripheral vestibular disorder in the guinea pig. Neurosci. Lett. 2000, 294:21-24.
49. Orita H., Shimogori H., Yamashita H. Unilateral intra-perilymphatic infusion of substance P enhances ipsilateral vestibulo-ocular reflex gains in the sinusoidal rotation test. Neurosci. Lett. 2009, 449:207-210.
50. Tam B.T.G., Foong K.H., Lee M.M.G., Ruan R. Polyethylenimine-mediated cochlear gene transfer in guinea pigs. Arch. Otolaryngol. 2008, 134:884-891.
51. Abaamrane L., Raffin F., Schmerber S., Sendowski I. Intracochlear perfusion of leupeptin and z-VAD-FMK: influence of antapoptotic agents on gunshot-induced hearing loss. Eur. Arch. Otorhinolaryngol. 2011, 268:987-993.
52. Sewell W.F., Borenstein J.T., Chen Z., Fiering J., Handzel O., Holmboe M., Kim E.S., Kujawa S.G., McKenna M.J., Mescher M.M., Murphy B., Swan E.E., Peppi M., Tao S. Development of a microfluidics-based intracochlear drug delivery device. Audiol. Neurootol. 2009, 14:411-422.
53. Chen Z., Kujawa S.G., McKenna M.J., Fiering J.O., Mescher M.J., Borenstein J.T., Swan E.E.L., Sewell W.F. Inner ear drug delivery via a reciprocating perfusion system in the guinea pig. J. Control. Release 2005, 110:1-19.
54. Handzel O., Wang H., Fiering J., Borenstein J.T., Mescher M.J., Swan E.E.L., Murphy B.A., Chen Z., Peppi M., Sewell W.F., Kujawa S.G., McKenna M.J. Mastoid cavity dimensions and shape: method of measurement and virtual fitting of implantable devices. Audiol. Neurootol. 2009, 14:308-314.
55. Sewell W.F., Borenstein J.T., Chen Z., Fiering J., Handzel O., Holmboe M., Kim E., Kujawa S.G., McKenna M.J., Mescher M.J., Murphy B.A., Swan E.E.L., Peppi M., Tao S.L. Development of a microfluidics-based intracochlear drug delivery device. Audiol. Neurootol. 2009, 14:411-422.
56. Pararas E.E.L., Chen Z., Fiering J., Mescher M.J., Kim E.S., McKenna M.J., Kujawa S.G., Borenstein J.T., Sewell W.F. Kinetics of reciprocating drug delivery to the inner ear. J. Control. Release 2011, 152:270-277.
57. Fiering J., Mescher M.J., Swan E.E.L., Holmboe M.E., Murphy B.A., Chen Z., Peppi M., Sewell W.F., McKenna M.J., Kujawa S.G., Borenstein J.T. Local drug delivery with a self-contained, programmable, microfluidic system. Biomed. Microdevices 2009, 11:571-578.
58. Mescher M.J., Swan E.E.L., Fiering J., Holmboe M., Sewell W.F., Kujawa S.G., McKenna M.J., Borenstein J.T. Fabrication methods and performance of low-permeability microfluidic components for a miniaturized wearable drug delivery system. IEEE J. MEMS 2009, 18:501-510.
59. Plontke S.K., Biegner T., Kammerer B., Delabar U., Salt A.N. Dexamethasone concentration gradients along scala tympani after application to the round window membrane. Otol. Neurotol. 2008, 29:401-406.
60. Chen Z., Mikulec A.A., McKenna M.J., Sewell W.F., Kujawa S.G. A method for intracochlear drug delivery in the mouse. J. Neurosci. Methods 2006, 150:67-73.
61. Oliver D., He D., Klocker N., Ludwig J., Schulte U., Waldegger S., Ruppersberg J., Dallos P., Fakler B. Intracellular anions as the voltage sensor of prestin, the outer hair cell motor protein. Science 2001, 292:2340-2343.
62. Salt A.N., Ohyama K., Thalmann R. Radial communication between the perilymphatic scalae of the cochlea. II Estimation by bolus injection of tracer into the sealed cochlea. Hear. Res. 1991, 56:37-43.
63. Gladstone M., Zhu X., Luebke A., Frisina R., Borkholder D.A. Using micro-computed tomography to asses transport parameters through fluid spaces of the cochlea. Biomedical Engineering Society National Conference, University of Texas at Austin 2010.
64. Shepherd R., Xu J. A multichannel scala tympani electrode array incorporating a drug delivery system for chronic intracochlear infusion. Hear. Res. 2002, 172:92-98.
65. Staecker H., Jolly C., Garnham C. Cochlear implantation: an opportunity for drug development. Drug Discov. Today 2010, 15:314-321.
66. Johnson D.G., Zhu X.X., Frisina R.D., Borkholder D.A. Micro-molded cannulae for intracochlear infusions in small rodents. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2007, 2007:6617-6620.
67. Johnson D.G., Waldron M.J., Frisina R.D., Borkholder D.A. Implantable micropump technologies for murine intracochlear infusions. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2010, 1:6441-6444.
68. Johnson D., Frisina R., Borkholder D. In-plane biocompatible microfluidic interconnects for implantable microsystems. IEEE Trans. Biomed. Eng. 2011, 58:943-948.
69. Johnson D., Getpreecharsawas J., Balasubramanian S., Datar A., Cormier D., Borkholder D.A. Hybrid MEMS: extending micro manufacturing with direct write processes. Technical Digest of Transducers Research Foundation Technologies for Future Micro-nano Manufacturing Workshop 2011.